About
Kimera Labs produces mesenchymal stem cell-derived exosomes for research and clinical applications. These exosomes capture regenerative signals from stem cells to support healing and tissue repair without using the cells themselves. The company focuses on high-purity production in controlled environments to enable precise therapeutic development.
They cultivate exosomes from isolated perinatal mesenchymal stem cells in chemically defined media free of animal or human serum. Advanced isolation and characterization ensure consistency and quality for potential use in therapeutics and diagnostics. This measured approach aims to advance health optimization through integrated biologic solutions.
Kimera Labs supports healthcare providers with education and evidence-based exosome science. Their facilities include clean rooms and specialized labs for ongoing innovation in regenerative modalities. The goal is sustainable progress in treatments that promote longevity and recovery.
Sources
Longevity Contribution
- Produces exosomes from isolated MSC cultures in chemically defined media without animal or human serum, unlike tissue-processed methods.
- Uses proprietary isolation technology and multi-modality characterization including dSTORM super resolution microscopy for highest purity.
- Operates FDA GMP-inspected facilities with ISO 5 hoods and class 7 clean rooms for scalable, consistent production.
- Supports clinical studies and develops indication-specific engineered exosomes with post-doctoral researchers.